Lung Volumes & Spirometry Reference Calculator

Lung Volumes and Spirometry Guide

What's the key thing to understand about Key Spirometry Measurements?

FVC (Forced Vital Capacity): total volume of air that can be forcibly exhaled after a maximal inhalation. FEV1 (Forced Expiratory Volume in 1 second): the volume exhaled in the first second of a forced exhalation. FEV1/FVC ratio: the percentage of the FVC exhaled in the first second — normally above 70-75%. TLC (Total Lung Capacity): total air in lungs at full inflation. RV (Residual Volume): air remaining after maximal exhalation (~1.2L). These measurements require a spirometer and follow a standardised testing protocol, giving reliable, comparable results between visits and between different people.

What's the difference between Obstructive and Restrictive Patterns?

Obstructive pattern (asthma, COPD, bronchiectasis): FEV1/FVC < 70%. FVC may be normal or mildly reduced. FEV1 is significantly reduced. The airways are narrowed — air cannot flow out rapidly in the first second but can eventually escape. COPD is graded by FEV1 as % predicted: Mild (GOLD 1) ≥80%, Moderate (GOLD 2) 50-79%, Severe (GOLD 3) 30-49%, Very severe (GOLD 4) <30%. Restrictive pattern (pulmonary fibrosis, obesity, kyphoscoliosis): FVC significantly reduced, FEV1 reduced proportionally, FEV1/FVC ratio normal or even elevated, since both values fall together proportionally rather than the ratio itself dropping.

What do I need to know about Reference Values and Ethnicity?

Predicted lung volumes are based on population reference values from the European Respiratory Society (ERS/GLI 2012 equations). Predicted values vary significantly with sex, age, and height. A person's measured FEV1 is expressed as % predicted — below 80% is considered below normal limit. Ethnicity: Black African/Caribbean individuals have lung volumes approximately 10-15% lower than White Europeans of the same height and age. South Asian individuals approximately 5-10% lower. Reference equations: various published correction factors exist, though their use remains debated in some clinical and research settings, since applying a population-average adjustment to an individual patient is not without controversy.

What's the key thing to understand about Spirometry in Clinical Practice?

Spirometry is the gold standard for diagnosing and monitoring obstructive lung disease (asthma, COPD). NICE guidelines: spirometry should be performed to confirm COPD diagnosis — clinical features alone are insufficient. Reversibility testing: FEV1 improvement ≥12% and ≥200mL after bronchodilator suggests asthma (reversible obstruction) rather than COPD (less reversible). Peak expiratory flow rate (PEFR): a simpler bedside test — useful for asthma monitoring but less accurate than full spirometry for diagnosing or monitoring most other respiratory conditions.

How Is the FEV1/FVC Ratio Used to Distinguish Disease Patterns?

The FEV1/FVC ratio — the proportion of total forced vital capacity exhaled within the first second — is one of the most useful single numbers in spirometry because the direction of its change helps distinguish between obstructive and restrictive lung disease patterns. In obstructive conditions (such as asthma or COPD), airflow is impeded, so FEV1 falls more than FVC, lowering the ratio below the normal threshold (commonly below 0.70, though age-adjusted lower limits of normal are increasingly preferred over a single fixed cutoff). In restrictive conditions (such as pulmonary fibrosis), both FEV1 and FVC tend to fall together because total lung volume itself is reduced, so the ratio can remain normal or even appear slightly elevated despite clearly abnormal absolute values. This pattern recognition is why spirometry reports typically present the ratio alongside the absolute FEV1 and FVC values rather than any one number in isolation.

Why Do Spirometry Results Need a Same-Day Bronchodilator Test for Some Patients?

When spirometry shows an obstructive pattern, clinicians often repeat the test 15-20 minutes after administering a bronchodilator (a medication that relaxes airway muscles) to assess reversibility — a significant improvement in FEV1 after the bronchodilator (commonly defined as at least 12% and 200ml improvement) suggests asthma, where airway narrowing is substantially reversible, whereas little to no improvement is more typical of COPD, where airway damage is more fixed and structural. This distinction meaningfully changes treatment approach, since asthma management emphasises anti-inflammatory and reversible bronchodilation strategies while COPD management focuses more on symptom control and slowing disease progression. This is one of several reasons a single spirometry reading, while useful, often cannot fully diagnose or distinguish between respiratory conditions without this kind of additional, context-specific testing.

What's the difference between Peak Flow and Full Spirometry?

A peak flow meter is a small, inexpensive handheld device that measures only peak expiratory flow (PEF) — the fastest speed air can be forced out of the lungs in a single sharp blow — and is commonly used at home by people with asthma to monitor day-to-day control and catch early warning signs of a flare-up. Full spirometry, done in a GP surgery or hospital lung function lab, measures a much fuller picture: forced vital capacity (FVC), forced expiratory volume in one second (FEV1), the FEV1/FVC ratio, and often a full flow-volume curve, sometimes repeated after a bronchodilator to see how much the airways open up with treatment. Peak flow is useful for trend-spotting in a condition someone already has and is already being monitored for, since a change from someone's own personal best is meaningful, but it isn't sensitive or specific enough to diagnose what's causing a breathing problem in the first place, or to distinguish between an obstructive pattern (like asthma or COPD) and a restrictive one. This is why a new or unexplained breathing symptom warrants full spirometry assessment rather than relying on a peak flow reading alone.

Worked Example: Classifying a Spirometry Result as Obstructive, Restrictive or Normal

A patient's spirometry shows FVC 3.8L (92% predicted) and FEV1 2.2L (68% predicted). FEV1/FVC ratio = 2.2 ÷ 3.8 = 0.58, or 58%.

A normal FVC combined with a reduced FEV1 and a ratio below the roughly 70% threshold is the classic obstructive pattern seen in asthma or COPD — airflow out of the lungs is impeded, but the lungs themselves can still hold a largely normal total volume. This pattern alone doesn't distinguish asthma from COPD; that typically requires a bronchodilator reversibility test, covered elsewhere on this page.

Static vs Dynamic Lung Volumes: TLC, RV, and FRC Explained

Spirometry measures dynamic volumes — volumes that depend on actively forced breathing effort, such as FVC and FEV1 — but several important static lung volumes can only be measured with more specialised equipment (body plethysmography or gas dilution techniques) because they involve air that can't be forcibly exhaled. Total Lung Capacity (TLC) is all the air the lungs can hold at maximum inflation. Residual Volume (RV) is the air that remains in the lungs even after a maximal forced exhalation — typically around 1.2 litres in an average adult — and exists because the airways and alveoli can't be fully collapsed. Functional Residual Capacity (FRC) is the air remaining after a normal, relaxed exhalation (as opposed to a forced one), representing the lung volume at rest between breaths. These static volumes matter clinically because restrictive lung disease characteristically reduces TLC, while conditions causing air trapping (such as emphysema) characteristically increase RV — distinctions that standard spirometry alone cannot make, which is why more detailed lung function testing is sometimes needed beyond a basic spirometer reading.

Lung Volume Changes During Pregnancy and With Obesity

Two common physiological states predictably reduce measured lung volumes without indicating lung disease, and clinicians account for this when interpreting results. During pregnancy, the growing uterus progressively pushes the diaphragm upward, reducing Functional Residual Capacity and Residual Volume by the third trimester even though Total Lung Capacity and FVC usually change comparatively little, since the chest wall partly compensates; this is a normal, expected mechanical effect rather than a sign of respiratory compromise. Obesity has a broadly similar mechanical effect — excess abdominal and chest wall tissue restricts full diaphragm movement and lung expansion, typically producing a mild-to-moderate restrictive-looking pattern on spirometry (reduced FVC with a preserved or even slightly increased FEV1/FVC ratio) that improves with weight loss rather than reflecting true lung tissue disease. Recognising these as mechanical rather than pathological restriction is an important part of correctly interpreting a reduced FVC in these two groups.